Shift Stakeholder Behavior in 30 Days, Not 12 Months.

Your Phase III data is impressive, and your launch strategy is ready. But getting healthcare professionals to change their habits is a completely different challenge.

Most commercial launches stall not because the science is weak, but because clinical habits are deeply ingrained. For us, this is not an abstract theory that we read about. We experienced this firsthand while detailing superior study data to physicians to drive brand adoption. BTS Consulting points out strategies to help overcome the hidden behavioral friction slowing down adoption across Pharma, MedTech, and Diagnostics.

Get Your 2-Week Behavioral Audit

Why Complex Assets Demand More Than Standard Marketing

Healthcare stakeholders don’t buy or prescribe solely on the basis of quantitative data.

They act on implicit habits, muscle memory, and risk avoidance:

In Pharma & Biotech: Clinicians default to familiar treatment pathways while under pressure to see a high volume of patients.
In MedTech & Devices: Surgeons hesitate to alter procedural muscle memory, while value access committees (VAC) stall sign-offs over perceived financial risk.
In Diagnostics: Labs reject new assays if the testing protocol requires a significant learning curve and introduces workflow disruption.

When your commercial strategy targets rational logic alone, you are fighting an uphill battle against human nature.

One Framework. Three Sector Applications.

We cannot change how people think. We aim to address the flow or content in your messaging that can trigger hesitation.

Sector	The Invisible Friction Point	The Behavioral Shift
Pharma & Biotech	Prescriber default habits and MOA data overload.	From: Explaining efficacy and safety. To: Impact on patients’ lives.
MedTech & Devices	Surgeon muscle memory and cost resistance from value access committee.	From: Presenting feature upgrades To: Business case and economic impact for the organization and value for patients.
Diagnostics	Lab workflow disruption and performance concerns.	From: Highlighting comparative assay sensitivity and specificity data To: Easy lab integration and real-world evidence (RWE).

Stop Waiting Months for Answers

Simply throwing money at a problem is unlikely to solve it. Having support from people who have worked in labs to develop drugs and diagnostic tests and have also sold them brings a different perspective. We move fast to unlock value where it matters most.

The 2-Week Audit

In 14 days, our team audits your current HCP brand messaging, sales rep detail sheets, and clinical collateral. We identify potential friction points impeding or delaying adoption and deliver an actionable reframing blueprint your commercial team can execute quickly.

Dissatisfied With Your Commercial Trajectory?

We understand that entrenched habits are difficult to break. We can analyze your messaging and materials and provide advice from decades of experience on overcoming obstacles to adoption.